References
- Pincus T, Callahan L F, Sale L F, Brooks A L, Payne L E, Vaughn W K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864–72
- Scott D L, Symmons D PM, Coulton B L, Popert A J. Long-term outcome of treating rheumatoid arthritis: Results after 20 years. The Lancet 1987; i: 1108–11
- Möttönen T T. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988; 47: 648–53
- Eberhardt K B, Rydgren L C, Pettersson H, Wollheim F A. Early rheumatoid arthritis — onset, course, and outcome over 2 years. Rheumatol Int 1990; 10: 135–42
- Van der Heijde D MFM, van Leeuwen M A, van Riel P LCM, Koster A M, van't Hof M A, van Rijswijk M H, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 26–34
- Luukkainen R, Kajander A, Isomäki H. Effect of gold on progression in rheumatoid arthritis. Scand J Rheumatol 1977; 6: 189–92
- Wolfe F, Hawley D J, Cathey M A. Measurement of the gold treatment effect in clinical practice: Evidence for effectiveness of intramuscular gold therapy. J Rheumatol 1993; 20: 797–802
- Epstein W V. Parenteral gold therapy for rheumatoid arthritis. A treatment whose time has gone. J Rheumatol 1989; 16: 1291–4
- Harth M. Gold in rheumatoid arthritis. Standard, substitute or shame?. J Rheumatol 1993; 20: 771–3
- Williams H J, Ward J R, Dahl S L, Clegg D O, Willkens R F, Oglesby T, et al. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 1988; 31: 702–13
- Situnake R D, Grindulis K A, McConkey B. Long term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987; 46: 77–83
- Situnayake R D, McConkey B. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: The effects of disease duration on treatment response. J Rheumatol 1990; 17: 1268–73
- Pullar T, Hunter J A, Capell H A. Effect of sulfasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987; 46: 398–402
- Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- Ritchie D M, Boyle J A, McInnes J M, Jasani M K, Dalakos T G, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393–406
- Scott J, Huskinsson E C. Graphic representation of pain. Pain 1976; 2: 175–84
- Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockholm) 1977; 18: 481–91
- Sigler J, Bluhm G, Duncan H, Sharp J, Ensign D, McCrum W. Gold salts in the treatment of rheumatoid arthritis. Ann Intern Med 1974; 80: 21–6
- Van der Heijde D M, van Riel P L, Nuver-Zwart I H, Gribnau F W, van de Putte L B. Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; 1: 1036–9
- Pullar T, Hunter J A, Capell H A. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 1983; 287: 1102–4
- The Australian multicenter clinical trial group. Sulfasalazine in early rheumatoid arthritis. J Rheumatol 1992; 19: 1972–7
- Hannonen P, Möttönen T, Hakola M, Oka M. Sulfasalazine in early rheumatoid arthritis. Arthritis Rheum 1993; 36: 1501–9